FIELD: medicine. SUBSTANCE: method involves taking living human brain tissue from various blood group patients in making neurosurgical operations by resecting uninjured brain regions and aqueous salt extraction is produced for preparing antigen. EFFECT: high quality brain extraction containing full set of cerebral antigens.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF ANTIBRAIN ANTIBODY IN BLOOD SERUM | 1997 |
|
RU2138814C1 |
| METHOD FOR PREDICTING POSTSURGICAL MALIGNANT TRANSFORMATION OF BENIGN CENTRAL NERVOUS SYSTEM TUMORS | 2000 |
|
RU2171470C1 |
| METHOD FOR DIAGNOSING THE CASES OF BENIGN AND MALIGNANT TUMORS | 1999 |
|
RU2154830C1 |
| METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
| METHOD OF DIAGNOSTICS OF IMPAIRED HEARING | 0 |
|
SU1332230A1 |
| METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CEREBRAL GROWTHS | 2013 |
|
RU2519151C1 |
| METHOD OF DIAGNOSING SPECIFIC ALLERGEN SENSITIZATION OF BODIES OF WORKERS IN HYDROLYTIC-YEAST PRODUCTION PLANTS | 1994 |
|
RU2146049C1 |
| MODIFIED PEPTIDE AND USING IT FOR CNS CANCER SCREENING AND THERAPEUTIC EFFECTIVENESS TESTS | 2009 |
|
RU2491291C2 |
| METHOD FOR SELECTING NEUROONCOLOGICAL PATIENTS FOR IMMUNOTHERAPY | 2005 |
|
RU2297632C2 |
